Summary
This paper discusses the role of the circadian clock in hippocampal aging and as a therapeutic target in Alzheimer's disease, with a focus on the potential of casein kinase 1δ and 1ε as feasible targets to improve sleep and cognition in people with Alzheimer's disease.
Categories
Dementia: The paper discusses dementia in the context of Alzheimer's disease and the potential for therapeutic interventions targeting the circadian clock.
Alzheimer's disease: The paper focuses on Alzheimer's disease, discussing its profound global consequences and the potential for therapeutic interventions targeting the circadian clock.
Sleep and insomnia: The paper discusses sleep disturbances in people with Alzheimer's disease and the potential for therapeutic interventions targeting the circadian clock.
Cognitive function and memory: The paper discusses cognitive decline and memory impairment in people with Alzheimer's disease and the potential for therapeutic interventions targeting the circadian clock.
Aging: The paper discusses the role of the circadian clock in hippocampal aging and the potential for therapeutic interventions targeting the circadian clock.
Author(s)
P Adler
Publication Year
2020
Related Publications
Dementia
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The effects of light and the circadian system on rhythmic brain function
Alzheimer's disease
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Phospholipase C families: Common themes and versatility in physiology and pathology
- Neurogenesis and specification of retinal ganglion cells
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
Sleep and insomnia
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
- Functional and morphological differences among intrinsically photosensitive retinal ganglion cells
- The impact of light from computer monitors on melatonin levels in college students
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance